aTyr Pharma to Present at the Baird 2018 Global Healthcare Conference
August 30 2018 - 8:00AM
aTyr Pharma, Inc. (Nasdaq:LIFE), a biotherapeutics company engaged
in the discovery and development of innovative medicines based on
novel immunological pathways, today announced that Sanjay Shukla,
M.D., M.S., president and chief executive officer, will present at
the Baird 2018 Global Healthcare Conference in New York City on
Thursday, September 6, 2018 at 12:15 p.m. Eastern Time.
Links to a live audio webcast and replay of the
presentation may be accessed on the aTyr website events page
at: http://investors.atyrpharma.com/events-and-webcasts. An
audio replay will be available for 90 days following the
event.
About aTyr
aTyr is a biotherapeutics company engaged in the
discovery and development of innovative medicines based on novel
immunological pathways. aTyr’s research and development efforts are
concentrated on a newly discovered area of biology, the
extracellular functionality of tRNA synthetases. aTyr has built a
global intellectual property estate directed to a potential
pipeline of protein compositions derived from 20 tRNA synthetase
genes. aTyr is focused on the therapeutic translation of the
Resokine pathway, comprised of extracellular proteins derived from
the histidyl tRNA synthetase gene family. ATYR1923 is a
clinical-stage product candidate, based on the Resokine pathway,
which binds to the neuropilin-2 receptor and is designed to
down-regulate immune engagement in interstitial lung diseases and
other immune-mediated diseases. For more information, please visit
http://www.atyrpharma.com.
Contact: |
Jason Spark |
Managing Director,
Canale Communications Inc. |
jason@canalecomm.com |
619-849-6005 |
aTyr Pharma (NASDAQ:LIFE)
Historical Stock Chart
From Aug 2024 to Sep 2024
aTyr Pharma (NASDAQ:LIFE)
Historical Stock Chart
From Sep 2023 to Sep 2024